Pancreatic Adenocarcinoma Metastatic Completed Phase 2 Trials for Ruxolitinib (DB08877)

Also known as: Metastatic Pancreatic Adenocarcinoma / Pancreatic carcinoma metastatic

IndicationStatusPhase
DBCOND0060224 (Pancreatic Adenocarcinoma Metastatic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01423604Study of Ruxolitinib in Pancreatic Cancer PatientsTreatment